BENEVAS HCT

Welcome to the Brand page for “BENEVAS HCT”, which is offered here for Olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide for the treatment of cardiovascular diseases including high blood pressure, congestive heart failure, diabetic nephropathy, atherosclerosis and stroke;hct;.

Its status is currently believed to be active. Its class is unavailable. “BENEVAS HCT” is believed to be currently owned by “Sankyo Company Limited”.


Owner:
SANKYO COMPANY LIMITED
Owner Details
Description:
Olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide for the treatment of cardiovascular diseases including high blood pressure, congestive heart failure, diabetic nephropathy, atherosclerosis and stroke;HCT;
Categories: